Large gap with delayed quotes
|
Last quote
04/25/2026
-
02:00:00
|
Bid
04/27/2026 -
14:52:47
|
Bid Volume |
Ask
04/27/2026 -
14:52:47
|
Ask Volume |
|---|---|---|---|---|
|
27.38
+0.04
(
+0.15% )
|
27.22
|
100 |
27.38
|
100 |
Analysis date: 24.04.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 03.10.2025.
Interest
Weak
Weak
Two stars since 13.02.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 03.10.2025 at a price of 27.14.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 13.02.2026.
4wk Rel Perf
11.39%
11.39%
The four-week dividend-adjusted overperformance versus SP500 is 11.39%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.05%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.02%.
Mkt Cap in $bn
2.52
2.52
With a market capitalization between $2 & $8bn, ACADIA HEALTHCARE CO. is considered a mid-cap stock.
G/PE Ratio
0.44
0.44
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
19.32
19.32
The estimated PE is for the year 2027.
LT Growth
8.45%
8.45%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
83
83
For 1% of index variation, the stock varies on average by 0.83%.
Correlation
0.15
0.15
Stock movements are totally independent of index variations.
Value at Risk
19.13
19.13
The value at risk is estimated at USD 19.13. The risk is therefore 69.87%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
10.10.2012
10.10.2012